Brief: Bharat Parenterals Says Innoxel Lifesciences Completes EU GMP Inspection By Belgium's FAMHP
28/11/2025 08:37
Nov 28 (Reuters) - Bharat Parenterals Ltd BATP.BO: INNOXEL LIFESCIENCES COMPLETES EU GMP INSPECTION BY BELGIUM'S FAMHP AUDIT COMPLETED WITH ZERO CRITICAL AND MAJOR OBSERVATIONS Source text: ID:nBSE8f028V Further company coverage: BATP.BO ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Bharat Parenterals
See all newsBrief: Bharat Parenterals Says U.S. FDA Conducts Surprise Inspection At Innoxel Lifesciences Vadodara Facility
India's Bharat Parenteral rebounds on successful completion of EU GMP inspection
Brief: Bharat Parenterals Says Innoxel Lifesciences Completes EU GMP Inspection By Belgium's FAMHP
India's Bharat Parenterals jump after unit clears US FDA inspection
Brief: Bharat Parenterals Secures $27 Mln Order For Pharmaceutical Products